The American Council on Science and Health is a Corporate Front Group

Print Email Share Tweet

The American Council on Science and Health (ACSH) is a front group for the tobacco, agrichemical, fossil fuel, cosmetics and pharmaceutical industries. Emails released from lawsuits against Monsanto in 2018 and leaked financial documents from 2012 reveal the ACSH’s corporate funding and its strategies to spin science in defense of corporate products to secure financial support from corporations.

Ties to Monsanto

August 2017: A series of emails about the American Council on Science and Health released via lawsuits against Monsanto reveal that Monsanto paid ACSH on an ongoing basis to help defend its embattled products. Monsanto executives described ACSH’s materials promoting and defending agrichemical products as “EXTREMELY USEFUL” [sic] and noted that ACSH was working with Monsanto to discredit the World Health Organization’s cancer panel report about the cancer risk of  glyphosate (read more about Monsanto PR strategy to discredit IARC here).

The emails show that ACSH staff wrote to Monsanto requesting “Monsanto’s continued, and much needed, support in 2015.” Some Monsanto staffers were uncomfortable working with ACSH but decided to pay them anyway, according to the emails. Monsanto’s senior science lead Daniel Goldstein wrote to colleagues: “I can assure you I am not all starry eyed about ACSH- they have PLENTY of warts- but: You WILL NOT GET A BETTER VALUE FOR YOUR DOLLAR than ACSH.”

July 11, 2017: Paul Thacker reported in the Progressive: “Monsanto ignored repeated questions about their financial support for the American Council on Science and Health.” ACSH Director Hank Campbell responded in a post: “I don’t care. If a large food corporation, like Whole Foods, or a smaller one, like Monsanto, wants to buy an ad here, they can. We will cash that check.”

June 1, 2017: Le Monde investigation into Monsanto’s “war on science” described ACSH as a key player in Monsanto’s communication and lobbying network (see English translation).

May 2017: Plaintiffs’ attorneys suing Monsanto over glyphosate cancer concerns stated in a brief:

“Monsanto quietly funnels money to ‘think tanks’ such as the ‘Genetic Literacy Project’ and the ‘American Council on Science and Health,’ organizations intended to shame scientists and highlight information helpful to Monsanto and other chemical producers.”

August 2013: Emails reveal that Monsanto tapped ACSH to publish a series of pro-GMO papers assigned to professors by Monsanto and merchandized by a PR firm:

Monsanto executive Eric Sachs wrote to the professors: “To ensure that the papers have the greatest impact, the American Council for Science and Health is partnering with CMA Consulting to drive the project. The completed policy briefs will be offered on the ACSH website … CMA and ACSH also will merchandize the policy briefs, including the development of media specific materials, such as op-eds, blog postings, speaking engagements, events, webinars, etc.”

The papers were published in the end by Jon Entine’s Genetic Literacy Project (a close ally of ACSH) with no disclosure of Monsanto’s role.

Leaked ACSH docs reveal corporate-defense funding strategy

A leaked 2012 ACSH financial summary reported by Mother Jones revealed that ACSH has received funding from a large number of corporations and industry groups with a financial stake in the science messaging ACSH promotes — and showed how ACSH solicits corporate donations for quid pro quo product-defense campaigns. For example, the document outlines:

  • Plans to pitch the Vinyl Institute which “previously supported chlorine and health report”
  • Plans to pitch food companies for a messaging campaign to oppose GMO labeling
  • Plans to pitch cosmetic companies to counter “reformulation pressures” from the Campaign for Safe Cosmetics
  • Efforts to court tobacco and e-cigarette companies

Mother Jones reported, “ACSH’s donors and the potential backers the group has been targeting comprise a who’s-who of energy, agriculture, cosmetics, food, soda, chemical, pharmaceutical, and tobacco corporations.” Funding details:

  • ACSH donors in the second half of 2012 included Chevron, Coca-Cola, the Bristol Myers Squibb Foundation, Dr. Pepper/Snapple, Bayer Cropscience, Procter and Gamble, Syngenta, 3M, McDonald’s, and tobacco conglomerate Altria. ACSH also pursued financial support from Pepsi, Monsanto, British American Tobacco, DowAgro, ExxonMobil Foundation, Philip Morris International, Reynolds American, the Koch family-controlled Claude R. Lambe Foundation, the Dow-linked Gerstacker Foundation, the Bradley Foundation and Searle Freedom Trust.
  • Reynolds American and Phillip Morris International were the two largest donors listed in the documents.

Ties to Syngenta

In 2011, ACSH published a book about “chemophobia” written by Jon Entine, who also has many close ties to Monsanto. Entine’s book defended atrazine, a pesticide manufactured by Syngenta, which was funding ACSH.

A 2012 Mother Jones article describes the circumstances leading up to the publication. The article by Tom Philpott is based in part on internal company documents, obtained by the Center for Media and Democracy, describing Syngenta’s PR efforts to get third-party allies to spin media coverage of atrazine.

In one email from 2009, ACSH staff asked Syngenta for an additional $100,000 – “separate and distinct from general operating support Syngenta has been so generously providing over the years” – to produce an atrazine-friendly paper and “consumer-friendly booklet” to help educate media and scientists.

Email from ASCH staffer Gil Ross to Syngenta seeking funding for science project on atrazine “controversy” to include a peer reviewed paper and accompanying “consumer friendly booklet”:

A year and a half later, ACSH published Entine’s book with this release: “The American Council on Science and Health is pleased to announce a new book and companion friendly, abbreviated position paper … authored by Jon Entine.” Entine denied any relationship with Syngenta and told Philpott he had “no idea” Syngenta was funding ACSH.

ACSH Personnel

  • ACSH’s longtime “Medical/Executive Director” Dr. Gilbert Ross was convicted in a scheme to defraud the Medicaid system prior to joining ACSH. See court documents about Dr. Ross’ multiple fraud convictions and sentencing, and article in Mother Jones “Paging Dr. Ross” (2005). Dr. Ross was found to be a “highly untrustworthy individual” by a judge who sustained the exclusion of Dr. Ross from Medicaid for 10 years (see additional references and court document).
  • In June 2015, Hank Campbell took over ACSH leadership from acting president (and convicted felon) Dr. Gilbert Ross. Campbell worked for software development companies before starting the website Science 2.0 in 2006. In his 2012 book, “Science Left Behind: Feel Good Fallacies and the Rise of the Anti Science Left,” Campbell describes his background: “six years ago… I decided I wanted to write science on the Internet … with nothing but enthusiasm and a concept, I approached world famous people about helping me reshape how science could be done, and they did it for free.”

Incorrect statements about science 

ACSH has:

  • Claimed that “There is no evidence that exposure to secondhand smoke involves heart attacks or cardiac arrest.” Winston-Salem Journal, 2012
  • Argued that “there is no scientific consensus concerning global warming.” ACSH, 1998
  • Argued that fracking “doesn’t pollute water or air.” Daily Caller, 2013
  • Claimed that “There has never been a case of ill health linked to the regulated, approved use of pesticides in this country.” Tobacco Documents Library, UCSF, The Advancement of Sound Science Coalition document page 9, 1995
  • Declared that “There is no evidence that BPA [bisphenol A] in consumer products of any type, including cash register receipts, are harmful to health.” ACSH, 2012
  • Argued that the exposure to mercury, a potent neurotoxin, “in conventional seafood causes no harm in humans.” ACSH, 2010.

Recent ACSH messaging continues in the same theme, denying risk from products that are important to the chemical, tobacco and other industries, and making frequent attacks on scientists, journalists and others who raise concerns.

  • A 2016 “top junk science” post by ACSH denies that chemicals can cause endocrine disruption; defends e-cigarettes, vaping and soda; and attacks journalists and the Journal of the American Medical Association.

USA Today gives ACSH a platform 

USA Today continues to publish columns by ACSH president Hank Campbell and senior fellow Alex Berezow, who is also member of USA Today’s Board of Contributors, without disclosing their funding ties to corporations whose interests they defend.

In February 2017, 30 health, environmental, labor and public interest groups wrote to the editors of USA Today asking the paper to stop providing a platform of legitimacy to ACSH or at least provide full disclosures about who funds the group.

The letter states:

  • “We are writing to express our concern that USA Today continues to publish columns written by members of the American Council on Science and Health (ACSH), a corporate-funded group with a long history of promoting corporate agendas that are at odds with mainstream science. USA Today should not be helping this group promote its false identity as a credible, independent source on science. Your readers deserve accurate information about what and whom this group represents, as they reflect on the content of the columns.”
  • “These are no idle allegations. Many of the undersigned health, environmental, labor and public interest groups have been tracking ACSH’s work over the years. We have documented instances in which the group has worked to undermine climate change science, and deny the health threats associated with various products, including second-hand smokefrackingpesticides and industrial chemicals – all without being transparent about its corporate backers.”
  • We note that financial documents obtained by Mother Jones show that ACSH has received funding from tobacco, chemical, pharmaceutical and oil corporations. Public interest groups have reported that ACSH received funding from the Koch Foundations between 2005-2011, and released internal documents showing that ACSH solicited $100,000 from Syngenta in 2009 to write favorably about its product atrazine – a donation that was to be “separate and distinct from general operating support Syngenta has been so generously providing over the years.”
  • “At a time when the public is questioning the legitimacy of the news media, we believe it is vital for publications such as USA Today to follow the highest standards of journalistic ethics and serve the public with as much truth and transparency as possible. We respectfully ask you to refrain from publishing further columns authored by members of the American Council on Science and Health, or at the very least require that the individuals identify the organization accurately as a corporate-funded advocacy group.”

As of December 2017, USA Today editorial page editor Bill Sternberg has declined to stop publishing ACSH columns and the paper has repeatedly provided inaccurate or incomplete disclosures for the columns, and failed to notify its readers about ACSH’s funding from corporations whose agenda they promote.

Newsweek’s Bizarre Standard for Opinion Writers

Print Email Share Tweet

Update 2/6/18
Upheaval at Newsweek: The news outlet is imploding amid a financial scandal and poor leadership. Some editors “recklessly sought clicks at the expense of accuracy, retweets over fairness … I’ve never seen more reckless leadership,” wrote Newsweek’s political editor Matthew Cooper in his resignation letter.

By Stacy Malkan, 1/31/2018

Facts don’t matter in commentaries printed by Newsweek so long as the writer “seems genuine.”  That’s the takeaway from a troubling email exchange I had with Newsweek Opinion Editor Nicholas Wapshott after I raised concerns about a commentary in Newsweek attacking the organic industry.

The organic hit piece carried the byline of Henry I. Miller, who lost his platform at Forbes last year after the New York Times revealed that Miller had published an article in Forbes under his own name that was actually written by Monsanto.

In his recent Newsweek article, Miller spent several paragraphs attacking Danny Hakim, the New York Times reporter who wrote about that ghostwriting scandal; but Miller didn’t disclose to readers either the scandal or his collaborations with Monsanto.

Yet Monsanto’s fingerprints were all over Miller’s Newsweek article, as I reported here.

Miller made false claims about organic farming using pesticide industry sources.

Miller used pesticide industry sources to make false claims about organic farming and attacked people who were named on a target list that had been developed by Monsanto and Jay Byrne, Monsanto’s former director of corporate communications, who was quoted in Miller’s piece with no mention of the Monsanto affiliation.

None of this appears to bother Newsweek Opinion Editor Nicholas Wapshott, according to an on-the-record email exchange.

Miller ‘Flatly Denies’ Facts 

On Jan. 22, I emailed Wapshott to raise concerns that Newsweek continues to publish Miller’s commentaries without disclosing his relationship with Monsanto. I told him I was writing a story, and asked if he was aware that:

1) The New York Times reported in August that Miller had been caught publishing an article ghostwritten by Monsanto under his own name in Forbes, in violation of Forbes’ policy. Forbes ended its relationship with Miller and deleted all his articles from the site.

2) A 2015 internal Monsanto PR plan (recently released by lawyers involved in litigation against Monsanto) lists “Engage Henry Miller” as one of its first action items.

3) A source Miller used in his Newsweek article, Jay Byrne, is a former Monsanto employee (not identified as such). According to emails I reported here, Byrne worked with Monsanto to set up a front group of “independent” academics, secretly funded by industry, who attacked the organic industry as a “marketing scam,” the same theme in Miller’s Newsweek article.

4) Miller has a long history of partnering with – and pitching his PR services to – corporations that need help convincing the public their products aren’t dangerous and don’t need to be regulated.

Wapshott responded, “Hi Stacy, I understand that you and Miller have a long history of dispute on this topic. He flatly denies your assertions. Nicholas”

I wrote back to ask for clarification.

Hi Nicholas, to clarify:

Miller denies he published a column ghostwritten by Monsanto under his own name in Forbes and that Forbes has since deleted all his articles? (NYT story, Retraction Watch story)

Miller denies the Monsanto’s PR plan to address the IARC cancer rating of glyphosate lists “Engage Henry Miller” on page 2, item 3?

Miller denies that Jay Byrne, the former Monsanto employee not identified as such in his Newsweek article, was involved with setting up Academics Review as a front group? (Byrne has not denied writing these emails.)

Miller and I have disagreed yes, we were on opposite sides of a political campaign to label GMOs, but the above facts are facts, and provable. Do you think it’s fair to your readers to continue to publish his work without disclosing his ties to Monsanto?

Wapshott responded, “I think so. I have met Miller and he seems genuine. And I find it hard to believe that his flat denial is a lie. We would need a full trial to determine the truth and those resources are, thank goodness, beyond our means.”

Jumbled Mix of Conflict Disclosures

I find it hard to believe that his flat denial is a lie.

I wrote back to Wapshott once more, pointing out that a trial is not necessary in the Miller case, since the facts have been established by reporting in the New York Times and corroborated by Forbes’ spokeswoman Mia Carbonell, who told the Times:

“All contributors to Forbes.com sign a contract requiring them to disclose any potential conflicts of interest and only publish content that is their own original writing. When it came to our attention that Mr. Miller violated these terms, we removed his blog from Forbes.com and ended our relationship with him.”

Does Newsweek have a similar policy to require writers to disclose potential conflicts of interest and use only their own writing? 

Newsweek editors have not responded to that query. But the problem of weak, confused or non-existent conflict-of-interest disclosure standards goes far beyond Newsweek.

For a 2015 article in CJR, journalist Paul Thacker asked 18 media organizations that cover science to describe their disclosure standards for both journalists and the sources they use in their stories, and 14 responded.

“The responses present a jumbled mix of policies,” Thacker wrote. “Some draw a bright line — preventing journalists from having financial ties to any outside sources. Others allow some expenses and speaking fees. To complicate matters further, some organizations have written rules, while others consider incidents on a case-by-case basis. Standards advocated by professional societies also seem to differ.”

Some outlets apply different standards to reporters and columnists, as I learned when I asked why Washington Post food columnist Tamar Haspel can take speaking fees from agrichemical industry groups while writing about that industry as part of her regular column beat. Reporters at Washington Post aren’t allowed to do that, but in the case of columnists, the editor decides.

It’s all very murky. And some outlets are clearly crossing a bright line by publishing the views of groups and people who work with corporations to promote pro-industry science views without telling readers about the corporate collaboration.

Henry Miller’s attack on organic food in Newsweek is one example. Another is USA Today’s regular publication of science columns from the American Council on Science and Health, a front group for the tobacco, chemical, fossil fuel, pharmaceutical and other industries seeking to discredit scientific information about the harm of their products.

USA Today Lends Platform to Corporate Front Group  

In February 2017, two dozen health, environmental, labor and public interest groups wrote to the editors of USA Today asking the paper to stop publishing science columns by the American Council on Science and Health (ACSH), or at least provide full disclosures about who funds the group.

Leaked financial documents from 2013 reveal that ACSH solicits money from corporations to defend and promote their products; for example, ACSH spins science on fracking, e-cigarettes, toxic cosmetics and agrichemical industry products, and solicits funding from those industries in exchange. Recent reporting establishes that ACSH works with Monsanto on messaging campaigns.

“USA Today should not be helping this group promote its false identity as a credible, independent source on science,” the two dozen groups wrote to the editors. “Your readers deserve accurate information about what and whom this group represents, as they reflect on the content of the columns.”

Nearly a year later, USA Today is still publishing columns by ACSH staff and still failing to notify its readers about ACSH’s funding from corporations whose agenda they promote.

In an email response dated March 1, 2017, USA Today Editorial Page Editor Bill Sternberg explained:

“To the best of our knowledge, all of the columns in question were authored or co-authored by Alex Berezow, a longtime member of USA TODAY’s Board of Contributors. Mr. Berezow has written some 25 op-eds for us since 2011, and we consider him to be a credible voice on scientific issues. He holds a PhD in microbiology from the University of Washington, was the founding editor of RealClearScience and has contributed to a number of mainstream outlets.”

Berezow is now a senior fellow at ACSH, and his “@USAToday contributor” status appears in his bio on Twitter, where he frequently attacks critics of the pesticide industry, for example this recent vile tweet featuring a sexually graphic illustration of a nurse giving a patient a coffee enema.

Does USA Today really want to be associated with this type of science communication?

Integrity and Transparency in Science Reporting

News outlets can do better than these examples at Newsweek and USA Today, and they must do better. They can start by refusing to publish columns by corporate front groups and PR surrogates who pose as independent science thinkers.

They can implement clear and strong policies that require all columnists and journalists to disclose potential conflicts of interest for themselves and the sources they cite in their work.

At a time when the public is questioning the legitimacy of the news media, it is more important than ever for all publications to follow the highest standards of journalistic ethics and serve the public with as much truth and transparency as possible.

Sign up here to receive regular updates from the US Right to Know investigations
Donate here to keep our investigation cooking